Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 13,015 | 12,807 | 10,003 | 8,720 | 11,867 |
| Cost of Goods | 5,836 | 4,506 | 4,561 | 3,652 | 4,520 |
| Gross Profit | 7,179 | 8,301 | 5,442 | 5,068 | 7,347 |
| Operating Expenses | 36,854 | 20,286 | 17,371 | 25,085 | 21,446 |
| Operating Income | -28,839 | -11,479 | -11,368 | -19,365 | -13,579 |
| Interest Expense | 4,273 | 4,273 | 4,276 | 4,278 | 4,224 |
| Other Income | 1,252 | 306 | 2,096 | 713 | 734 |
| Pre-tax Income | -31,860 | -15,446 | -13,548 | -22,930 | -17,069 |
| Net Income Continuous | -31,860 | -15,446 | -13,548 | -22,930 | -17,055 |
| Net Income | $-31,860 | $-15,446 | $-13,548 | $-22,930 | $-17,055 |
| EPS Basic Total Ops | -0.26 | -0.14 | -0.14 | -0.24 | -0.18 |
| EPS Basic Continuous Ops | -0.27 | -0.14 | -0.14 | -0.24 | -0.18 |
| EPS Diluted Total Ops | -0.26 | -0.14 | -0.14 | -0.24 | -0.18 |
| EPS Diluted Continuous Ops | -0.27 | -0.14 | -0.14 | -0.24 | -0.18 |
| EPS Diluted Before Non-Recurring Items | -0.26 | -0.14 | -0.14 | -0.24 | -0.19 |
| EBITDA(a) | $-25,960 | $-8,592 | $-8,480 | $-16,476 | $-10,733 |